CSBR 株価分析 — Champions Oncology Inc (Healthcare >> Biotechnology)
CSBR に関するよくある質問
CSBRのPER(株価収益率)は?
Champions Oncology Inc(CSBR)は現在PER 240.10倍で取引されています。
CSBRのROE(自己資本利益率)は?
Champions Oncology IncのROEは-29.83%です。
CSBRの配当利回りは?
Champions Oncology Incの配当利回りは0.00%です。
CSBRの品質スコア(Quality Score)は?
当社のAIはCSBRの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
CSBRは今が買い時ですか?
当社AIのタイミングスコアは100点中0点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
CSBRはどのセクターに属しますか?
Champions Oncology IncはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)
CSBR AI Analysis Summary
Our AI summary for CSBR: Champions Oncology Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 240.10, ROE of -29.83%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 5.19
Price
-0.11
(-2.08%)
Day Change
|
|
|---|
CSBR, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1775
|
| Magic Formula Rank by ROE |
1775
|
| Magic Formula Rank by ROIC |
1794
|
| Price | 5.19 |
| PBV / Sector |
17.65 / 5.21
|
| Earning Per Share | -0.08 |
| PE / Sector |
240.10 / 21.00
|
| PEG or PE/Growth / Sector |
-3.84 / 1.11
|
| Average 1M Daily Value |
0.05 M
GREAT
|
| Average 1W Daily Value |
0.06 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-07 08:11:30 |
| Symbol | CSBR |
| Name | CHAMPIONS ONCOLOGY INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 13.89 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 71.79 / 9,672.56 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: One University Plaza, Hackensack, NJ, United States, 07601
Phone: 201 808 8400
Website: https://www.championsoncology.com
Employees: 214
Sector: Healthcare >> Biotechnology
Description: Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google